SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : BCRX: Target practice for shorts -- Ignore unavailable to you. Want to Upgrade?

To: Wolff who wrote (63)9/2/1999 9:32:00 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 96
 
Wolff:

I dunno..... do developing children get CTCL? I don't think so.

But, I'm curious.... why would anyone ask a question like that?

Again, I don't own a position of any kind in this security and never have.

Rick



To: Wolff who wrote (63)9/2/1999 2:09:00 PM
From: Biomaven  Read Replies (1) | Respond to of 96
 
this drug or clear fluids and rest you take your pick.

The question is would you give a developing child BCX-34.

I don't think "clear fluids and rest" would do much for the conditions for which BCX-34 is being developed. This is a quite different drug for quite different conditions than the 'flu drug in case you hadn't yet noticed.

Peter (still no BCRX position)


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News